Email ID
Sign me in automatically next time
Will Berinert's US OK for self-administration put Shire's Firazyr on the run?

With the US FDA granting CSL Behring permission to market its hereditary angioedema (HAE) drug Berinert, a plasma-derived C1 inhibitor replacement product, as a self-administered medicine for acute...
04 January 2012
Donna Young

Please Login to read the full article.
20 January 2016
PGA National, Palm Beach Gardens, FL
© 2015 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36